Share on LinkedInShare on LinkedIn

ARTICLE · 06 MAY 2021

PMPRB Seeks Feedback On Guideline Monitoring And Evaluation Plan

Gowling WLG
Gowling WLG
Contributor
Gowling WLG

Gowling WLG

The firm The firm’s lawyers speak English, French, Russian and Ukrainian. The firm’s client base...

View firm profile
Explore more from Gowling WLG

The PMPRB announced a new initiative called the Guideline Monitoring and Evaluation Plan (GMEP), through which the PMPRB will seek to "monitor and evaluate trends in the pharmaceutical market that...

CanadaIntellectual Property

The PMPRB announced a new initiative called the Guideline Monitoring and Evaluation Plan (GMEP), through which the PMPRB will seek to "monitor and evaluate trends in the pharmaceutical market that may impact patentees, as well as the consumers, patients and payers that they are mandated to protect."1

The new initiative will analyze trends in the pharmaceutical market, before and after the implementation of the new patented medicines framework on July 1, 20212, to assess whether it is working as intended, and to inform the need for any future adjustments. While it is not the first evaluation plan of its kind, the PMPRB says that it will be the most comprehensive due to the "unparalleled scale and scope of the changes reflected in the new Guidelines."

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from